Loblaw targets 8-10% EPS growth at upcoming Investor Day
- Loblaw hosts "Retail and Beyond" Investor Day on September 9, 2026
- Targets 8-10% annual adjusted diluted net EPS growth long-term
- High-growth businesses to contribute ~10% of operating income in 2026
- Earnings from new platforms expected to double by 2031

*this image is generated using AI for illustrative purposes only.
Loblaw Companies Limited (TSX: L) will host its "Retail and Beyond" Investor Day on September 9, 2026. The event aims to outline the company’s strategy for profitable growth across its core retail businesses and emerging platforms.
Management plans to provide updates on its Super Market, Hard Discount, and Shoppers Drug Mart divisions. The presentation will also cover growth areas including supply chain as a service, retail media, data initiatives, Lifemark, and T&T’s expansion into the U.S. market.
Strategic Framework
The company’s business strategy supports a long-term financial framework targeting annual adjusted diluted net earnings per common share growth of approximately 8% to 10%. Loblaw intends to leverage its scale and operational efficiencies to reinvest in customer value and service.
Per Bank, President and Chief Executive Officer, stated that retail excellence remains central to the company’s operations. He noted that capabilities built around this core create opportunities to serve customers in new ways while generating profitable growth over the long term.
Growth Platforms
Loblaw has invested in complementary businesses beyond its core retail portfolio. These include supply chain as a service, retail media and data, and Lifemark. Along with contributions from EQB Inc. and T&T’s U.S. expansion, these businesses are expected to collectively generate approximately 10% of the company’s operating income in 2026.
The company expects the collective earnings contribution from these higher-growth businesses to double by 2031. This expansion reflects a strategic shift toward diversifying revenue streams beyond traditional food and drug retail.
| Business Segment | Expected Operating Income Contribution (2026) | Earnings Contribution Target (2031) |
|---|---|---|
| High Growth Businesses | ~10% | Double 2026 levels |
Financial Outlook
Unless otherwise expressly stated, the information contained in the Investor Day presentation does not modify or replace the company’s previously disclosed 2026 financial outlook. The 2026 financial outlook remains as set out in the second quarter 2026 earnings release and Management’s Discussion and Analysis.
The event will be available via live webcast starting at 8:30 am ET on September 9, 2026. Presentation materials will be filed on SEDAR+ and available on the company’s website.
How might the expansion of T&T into the U.S. market impact Loblaw's competitive positioning against other Canadian retailers with cross-border ambitions?
What specific operational hurdles could prevent the high-growth businesses from achieving their target of doubling earnings contribution by 2031?
To what extent will the integration of 'supply chain as a service' diversify Loblaw's revenue streams away from traditional retail margins?





























